首页> 美国卫生研究院文献>Experimental Diabetes Research >Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial
【2h】

Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial

机译:在改善代谢控制方面同伴支持计划与常规护理在2型糖尿病疾病管理中的有效性:一项集群随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aim. Testing the effectiveness of peer support additionally to a disease management programme (DMP) for type 2 diabetes patients. Methods. Unblinded cluster-randomised controlled trial (RCT) involving 49 general practices, province of Salzburg, Austria. All patients enrolled in the DMP were eligible, n = 337 participated (intervention: 148 in 19 clusters; control: 189 in 20 clusters). The peer support intervention ran over 24 months and consisted of peer supporter recruitment and training, and group meetings weekly for physical exercise and monthly for discussion of diabetes related topics. Results. At two-year follow-up, adjusted analysis revealed a nonsignificant difference in HbA1c change of 0.14% (21.97 mmol/mol) in favour of the intervention (95% CI −0.08 to 0.36%, p = 0.22). Baseline values were 7.02 ± 1.25% in the intervention and 7.08 ± 1.25 in the control group. None of the secondary outcome measures showed significant differences except for improved quality of life (EQ-5D-VAS) in controls (4.3 points on a scale of 100; 95% CI 0.08 to 8.53, p = 0.046) compared to the intervention group. Conclusion. Our peer support intervention as an additional DMP component showed no significant effect on HbA1c and secondary outcome measures. Further RTCs with a longer follow-up are needed to reveal whether peer support will have clinically relevant effects. Trial Registration. This trial has been registered with Current Controlled Trials Ltd. ().
机译:目标。在2型糖尿病患者的疾病管理计划(DMP)之外,还测试了同伴支持的有效性。方法。奥地利萨尔茨堡州的49项常规操作的无盲聚类随机对照试验(RCT)。参加DMP的所有患者均符合条件,n = 337参与(干预:19组为148名;对照组:20组为189名)。同伴支持干预持续了24个月,包括同伴支持者的招募和培训,以及每周进行的小组运动和每月的小组讨论糖尿病相关主题的会议。结果。在为期两年的随访中,调整后的分析显示,HbA1c的变化无明显差异,为0.14%(21.97 mmol / mol),有利于干预(95%CI -0.08至0.36%,p = 0.22)。干预组的基线值为7.02±1.25%,对照组为7.08±1.25。与干预组相比,除了对照组的生活质量得到改善(EQ-5D-VAS)(100分时为4.3分; 95%CI为0.08至8.53,p = 0.046)外,没有任何次要结果指标显示出显着差异。结论。我们的同伴支持干预作为DMP的附加成分,对HbA1c和次要结局指标没有显着影响。需要更多具有更长随访时间的RTC,以揭示同伴支持是否将具有临床相关的作用。试用注册。该试验已在Current Controlled Trials Ltd.()注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号